Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens

Kyra J. Fuchs, Marian van de Meent, M. Willy Honders, Indu Khatri, Michel G. D. Kester, Eva A. S. Koster, Georgia Koutsoumpli, Arnoud H. de Ru, Cornelis A. M. van Bergen, Peter A. van Veelen, Peter A. C. ’t Hoen, Peter van Balen, Erik B. van den Akker, J. Hendrik Veelken, Constantijn J. M. Halkes, J. H. Frederik Falkenburg, Marieke Griffioen

Blood (2024) 143 (18): 1856–1872.

https://doi.org/10.1182/blood.2023022343

Published: 2024

Includes: Supplemental data

Journal Articles

Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid Leukemia

Georgia Koutsoumpli, Dyantha I. van der Lee, Nina C. Groenland, M. Willy Honders, Rob C.M. de Jong, Renate S. Hagedoorn, Hendrik Veelken, Peter A. van Veelen, Dominik Lock, Mirjam H.M. Heemskerk, J.H.Frederik Falkenburg, Ian Johnston, Marieke Griffioen

Blood (2022) 140 (Supplement 1): 10243–10244.

https://doi.org/10.1182/blood-2022-158195

Published: 2022

Journal Articles

Large Scale Identification and Validation of 85 New HLA Class I-Restricted Minor Histocompatibility Antigens for Immune Monitoring and Modulation after Allogeneic Stem Cell Transplantation

Kyra J. Fuchs, M. Willy Honders, Marian van de Meent, Indu Khatri, Eva A.S. Koster, Cornelis A.M. van Bergen, Erik B. van den Akker, Constantijn J.M. Halkes, J.H. Frederik Falkenburg, Marieke Griffioen

Blood (2022) 140 (Supplement 1): 10196–10197.

https://doi.org/10.1182/blood-2022-157938

Published: 2022

Journal Articles

Whole Transcriptome RNA Sequencing As a Comprehensive Diagnostic Tool for Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 2762.

https://doi.org/10.1182/blood-2018-99-111115

Published: 2018

Journal Articles

Fusion Transcripts without Corresponding Cytogenetic Abnormalities in Acute Myeloid Leukemia: Implications for AML Pathogenesis

Irene J. Locher, Wibowo Arindrarto, M.Sc., Daniel M. Borràs, M.Sc., M. Willy Honders, ing., Rick H. de Leeuw, ing., Wilma G.M. Kroes, PhD, Peter de Knijff, PhD, Cornelis A.M. van Bergen, PhD, Peter A.C. 't Hoen, PhD, Szymon M. Kielbasa, PhD, Jeroen F.J. Laros, PhD, Marieke Griffioen, PhD, Hendrik Veelken, MD PhD

Blood (2017) 130 (Supplement 1): 2703.

https://doi.org/10.1182/blood.V130.Suppl_1.2703.2703

Published: 2017

Journal Articles

Whole Transcriptome Sequencing (RNAseq) As a Comprehensive, Cost-Efficient Diagnostic Tool for Acute Myeloid Leukemia

Marieke Griffioen, PhD, Wibowo Arindrarto, MSc, Daniel Borràs, MSc, Saskia A.M.E. van Diessen, BSc, Edith D. van der Meijden, M. Willy Honders, Mariam Alloul, PhD, Inge Jedema, PhD, Wilma G.M. Kroes, PhD, Peter J.M. Valk, PhD, Bart Janssen, PhD, Cornelis A.M. van Bergen, PhD, Szymon M. Kiełbasa, PhD, Jeroen F.J. Laros, PhD, Peter A.C. 't Hoen, PhD, Hendrik Veelken, MD PhD

Blood (2016) 128 (22): 1701.

https://doi.org/10.1182/blood.V128.22.1701.1701

Published: 2016

Journal Articles

LB-ARHGDIB-1R As Novel Minor Histocompatibility Antigen For Therapeutic Application

Margot J Pont, Willemijn Hobo, PhD, M. Willy Honders, Simone A.P. van Luxemburg-Heijs, Michel G.D. Kester, Cornelis A.M. van Bergen, Harry Dolstra, PhD, J.H. Frederik Falkenburg, MD, PhD, Marieke Griffioen, PhD

Blood (2013) 122 (21): 4465.

https://doi.org/10.1182/blood.V122.21.4465.4465

Published: 2013

Journal Articles

Diversity of HLA Class I and Class II Restricted Minor Histocompatibility Antigens in Graft-Versus-Leukemia Reactivity.

Marieke Griffioen, M. Willy Honders, Anita N. Stumpf, Edith D. van der Meijden, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Elisabeth G.A. Lurvink, Roel Willemze, J.H. Frederik Falkenburg

Blood (2009) 114 (22): 4084.

https://doi.org/10.1182/blood.V114.22.4084.4084

Published: 2009

Journal Articles

High Throughput Minor Histocompatibility Antigen Discovery by Whole Genome Association Scanning.

Cornelis A.M. van Bergen, Edith D. van der Meijden, Caroline E. Rutten, Simone A.P. van Luxemburg, Elisabeth G.A. Lurvink, M. Willy Honders, Jeanine J. Houwing, M. Lourdes Sampietro, Roelof Willemze, J.H. Frederik Falkenburg, Marieke Griffioen

Blood (2009) 114 (22): 685.

https://doi.org/10.1182/blood.V114.22.685.685

Published: 2009

Journal Articles

Detailed Analysis of CD8+ T Cell Immunity and Identification of a Novel Minor Histocompatibility Antigen Contributing to Graft-Versus- Leukemia Reactivity.

Marieke Griffioen, PhD, M. Willy Honders, Edith D. van der Meijden, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD

Blood (2008) 112 (11): 3250.

https://doi.org/10.1182/blood.V112.11.3250.3250

Published: 2008

Journal Articles

Identification of Phosphatidylinositol 4-Kinase Type II β as the First HLA Class II Associated Minor Histocompatibility Antigen Involved in Graft Versus Leukemia Reactivity.

Marieke Griffioen, Edith D. van der Meijden, M. Willy Honders, Caroline Rutten, Simone A.P. van Luxemburg-Heijs, Peter A. von dem Borne, Roelof Willemze, J.H. Frederik Falkenburg

Blood (2007) 110 (11): 1800.

https://doi.org/10.1182/blood.V110.11.1800.1800

Published: 2007

Journal Articles

Allo-HLA Reactive CD8 T-Cells May Recognize Tissue Specific Peptides Explaining Tissue Restricted GVHD after HLA Mismatched SCT.

Avital Amir, MD, Marieke Griffioen, PHD, Michel D.G. Kester, M. Willy Honders, Roelof Willemze, J.H. Frederik Falkenburg, Mirjam Heemskerk

Blood (2007) 110 (11): 72.

https://doi.org/10.1182/blood.V110.11.72.72

Published: 2007

Journal Articles

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer

Elisabeth H. Slager, M. Willy Honders, Edith D. van der Meijden, Simone A. P. van Luxemburg-Heijs, Freke M. Kloosterboer, Michel G. D. Kester, Inge Jedema, W. A. Erik Marijt, M. Ron Schaafsma, Roel Willemze, J. H. Frederik Falkenburg

Blood (2006) 107 (12): 4954–4960.

https://doi.org/10.1182/blood-2005-09-3883

Published: 2006

Journal Articles

Identification of the Angiogenic Endothelial Cell Growth Factor-1/Thymidine Phosphorylase as a Target for Immunotherapy of Cancer.

Elisabeth H. Slager, PhD, M. Willy Honders, Edith D. van der Meijden, Simone A.P. van Luxemburg-Heijs, Freke M. Kloosterboer, PhD, Michel G.D. Kester, Inge Jedema, PhD, W.A. Erik Marijt, PhD, MD, M. Ronald Schaafsma, PhD, MD, J.H. Frederik Falkenburg, PhD, MD, Roel Willemze, PhD, MD

Blood (2005) 106 (11): 3094.

https://doi.org/10.1182/blood.V106.11.3094.3094

Published: 2005

Journal Articles

Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells

Marjan J. T. Veuger, Mirjam H. M. Heemskerk, M. Willy Honders, Roel Willemze, Renée M. Y. Barge

Blood (2002) 99 (4): 1373–1380.

https://doi.org/10.1182/blood.V99.4.1373

Published: 2002

Journal Articles

High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia

Marjan J. T. Veuger, M. Willy Honders, Jim E. Landegent, Roel Willemze, Renée M. Y. Barge

Blood (2000) 96 (4): 1517–1524.

https://doi.org/10.1182/blood.V96.4.1517

Published: 2000

NARROW

Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens

Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid Leukemia

Large Scale Identification and Validation of 85 New HLA Class I-Restricted Minor Histocompatibility Antigens for Immune Monitoring and Modulation after Allogeneic Stem Cell Transplantation

Whole Transcriptome RNA Sequencing As a Comprehensive Diagnostic Tool for Acute Myeloid Leukemia

Fusion Transcripts without Corresponding Cytogenetic Abnormalities in Acute Myeloid Leukemia: Implications for AML Pathogenesis

Whole Transcriptome Sequencing (RNAseq) As a Comprehensive, Cost-Efficient Diagnostic Tool for Acute Myeloid Leukemia

LB-ARHGDIB-1R As Novel Minor Histocompatibility Antigen For Therapeutic Application

Diversity of HLA Class I and Class II Restricted Minor Histocompatibility Antigens in Graft-Versus-Leukemia Reactivity.

High Throughput Minor Histocompatibility Antigen Discovery by Whole Genome Association Scanning.

Detailed Analysis of CD8+ T Cell Immunity and Identification of a Novel Minor Histocompatibility Antigen Contributing to Graft-Versus- Leukemia Reactivity.

Identification of Phosphatidylinositol 4-Kinase Type II β as the First HLA Class II Associated Minor Histocompatibility Antigen Involved in Graft Versus Leukemia Reactivity.

Allo-HLA Reactive CD8 T-Cells May Recognize Tissue Specific Peptides Explaining Tissue Restricted GVHD after HLA Mismatched SCT.

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer

Identification of the Angiogenic Endothelial Cell Growth Factor-1/Thymidine Phosphorylase as a Target for Immunotherapy of Cancer.

Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells

High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only